Vindya Achuthan, MD
Internal Medicine · Middletown, NYNPI 1114104619
Payments from drug & device makers
Across 76 payments — averaging $25.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$448
- Abiomed$218
- Abbott$177
- UCB, Inc.$110
- GSK$83
- Jazz Pharmaceuticals Inc.$74
- plus $817 from 25 others
What the payments were for
- Food & beverage$1,928100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 13 | $448 |
| Abiomed | 2 | $218 |
| Abbott | 1 | $177 |
| UCB, Inc. | 6 | $110 |
| GSK | 6 | $83 |
| Jazz Pharmaceuticals Inc. | 5 | $74 |
| Cook Medical LLC | 1 | $73 |
| Novo Nordisk | 4 | $65 |
| Boehringer Ingelheim | 4 | $63 |
| Mylan Specialty L.p. | 4 | $61 |
| Harmony Biosciences LLC | 2 | $60 |
| Mannkind Corporation | 3 | $45 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Tolmar, Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Medtronic | 1 | $29 |
| Exact Sciences | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| United Therapeutics Corporation | 1 | $19 |
| Resmed Corp | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER Occluders$177
- Repatha$147
- EVENITY$125
How this compares
$1,928 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 34 | $35,879 |
| FarxigaDapagliflozin Propanediol | 18 | $17,961 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $8,836 |
| Rosuvastatin Calcium | 151 | $2,556 |
| Atorvastatin Calcium | 134 | $1,344 |
| Ezetimibe | 47 | $1,051 |
| Valsartan | 22 | $918 |
| Olmesartan Medoxomil | 19 | $814 |
| Pantoprazole Sodium | 29 | $788 |
| Levothyroxine Sodium | 70 | $720 |
| Losartan Potassium | 70 | $658 |
| Amlodipine Besylate | 114 | $639 |
| Bisoprolol Fumarate | 18 | $608 |
| Metformin Hcl ErMetformin Hcl | 58 | $517 |
| Metformin Hcl | 48 | $384 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $63 | $35,87934 claims |
| AstraZenecaFarxiga | $16 | $17,96118 claims |
| GSKAnoro Ellipta | $83 | $8,83613 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $72070 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Middletown
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.